Toll样受体4激动剂作为疫苗佐剂：化学家的视角 - Suppr

Suppr

超能文献

TLR4 agonists as vaccine adjuvants: a chemist's perspective.

作者信息

Johnson David A

出版信息

Expert Rev Vaccines. 2013 Jul;12(7):711-3. doi: 10.1586/14760584.2013.811189.

DOI:10.1586/14760584.2013.811189

PMID:23885814

Abstract

摘要

相似文献

TLR4 agonists as vaccine adjuvants: a chemist's perspective.

Expert Rev Vaccines. 2013 Jul;12(7):711-3. doi: 10.1586/14760584.2013.811189.

The RTS,S vaccine candidate for malaria.

Expert Rev Vaccines. 2011 May;10(5):589-99. doi: 10.1586/erv.11.57.

IABS international scientific workshop--Mode of Action of Adjuvants: implications for vaccine safety and design, April 29-30, 2010, Bethesda, MD, USA.

Vaccine. 2011 Apr 12;29(17):3340. doi: 10.1016/j.vaccine.2011.02.015. Epub 2011 Feb 16.

A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate.

Vaccine. 2011 Apr 12;29(17):3284-92. doi: 10.1016/j.vaccine.2011.02.022. Epub 2011 Feb 22.

TLR-based immune adjuvants.

Vaccine. 2011 Apr 12;29(17):3341-55. doi: 10.1016/j.vaccine.2010.08.002. Epub 2010 Aug 14.

12th Annual Conference on Vaccine Research.

Expert Rev Vaccines. 2009 Sep;8(9):1139-42. doi: 10.1586/erv.09.74.

When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes.

Vaccine. 2012 Mar 9;30(12):2042. doi: 10.1016/j.vaccine.2011.10.042. Epub 2011 Oct 30.

GSK seeks approval for world's first malaria vaccine.

Clin Infect Dis. 2014 Oct 15;59(8):ii.

Vaccine adjuvant safety: the elephant in the room.

Expert Rev Vaccines. 2013 Jul;12(7):715-7. doi: 10.1586/14760584.2013.811198.

TLR4 agonists as immunomodulatory agents.

J Endotoxin Res. 2006;12(5):313-9. doi: 10.1179/096805106X118753.

引用本文的文献

Enhancement of HPV therapeutic peptide-based vaccine efficacy through combination therapies and improved delivery strategies: A review.

Hum Vaccin Immunother. 2024 Dec 31;20(1):2396710. doi: 10.1080/21645515.2024.2396710. Epub 2024 Aug 28.

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants.

Chemistry. 2022 Jun 21;28(35):e202200547. doi: 10.1002/chem.202200547. Epub 2022 May 11.

Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo Activity.

J Med Chem. 2021 Aug 26;64(16):12261-12272. doi: 10.1021/acs.jmedchem.1c00896. Epub 2021 Aug 12.

Environmental Subconcussive Injury, Axonal Injury, and Chronic Traumatic Encephalopathy.

Front Neurol. 2018 Mar 27;9:166. doi: 10.3389/fneur.2018.00166. eCollection 2018.

Modulation of Toll-like receptor signaling in innate immunity by natural products.

Int Immunopharmacol. 2016 Aug;37:65-70. doi: 10.1016/j.intimp.2016.02.005. Epub 2016 Feb 15.

Characterization of TRIF selectivity in the AGP class of lipid A mimetics: role of secondary lipid chains.

Bioorg Med Chem Lett. 2015 Feb 1;25(3):547-53. doi: 10.1016/j.bmcl.2014.12.024. Epub 2014 Dec 17.

A comparative review of toll-like receptor 4 expression and functionality in different animal species.

Front Immunol. 2014 Jul 10;5:316. doi: 10.3389/fimmu.2014.00316. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

TLR4 agonists as vaccine adjuvants: a chemist's perspective.

Expert Rev Vaccines. 2013 Jul;12(7):711-3. doi: 10.1586/14760584.2013.811189.

The RTS,S vaccine candidate for malaria.

Expert Rev Vaccines. 2011 May;10(5):589-99. doi: 10.1586/erv.11.57.

IABS international scientific workshop--Mode of Action of Adjuvants: implications for vaccine safety and design, April 29-30, 2010, Bethesda, MD, USA.

Vaccine. 2011 Apr 12;29(17):3340. doi: 10.1016/j.vaccine.2011.02.015. Epub 2011 Feb 16.

A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate.

Vaccine. 2011 Apr 12;29(17):3284-92. doi: 10.1016/j.vaccine.2011.02.022. Epub 2011 Feb 22.

TLR-based immune adjuvants.

Vaccine. 2011 Apr 12;29(17):3341-55. doi: 10.1016/j.vaccine.2010.08.002. Epub 2010 Aug 14.

12th Annual Conference on Vaccine Research.

Expert Rev Vaccines. 2009 Sep;8(9):1139-42. doi: 10.1586/erv.09.74.

When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes.

Vaccine. 2012 Mar 9;30(12):2042. doi: 10.1016/j.vaccine.2011.10.042. Epub 2011 Oct 30.

GSK seeks approval for world's first malaria vaccine.

Clin Infect Dis. 2014 Oct 15;59(8):ii.

Vaccine adjuvant safety: the elephant in the room.

Expert Rev Vaccines. 2013 Jul;12(7):715-7. doi: 10.1586/14760584.2013.811198.

TLR4 agonists as immunomodulatory agents.

J Endotoxin Res. 2006;12(5):313-9. doi: 10.1179/096805106X118753.

引用本文的文献

Enhancement of HPV therapeutic peptide-based vaccine efficacy through combination therapies and improved delivery strategies: A review.

Hum Vaccin Immunother. 2024 Dec 31;20(1):2396710. doi: 10.1080/21645515.2024.2396710. Epub 2024 Aug 28.

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants.

Chemistry. 2022 Jun 21;28(35):e202200547. doi: 10.1002/chem.202200547. Epub 2022 May 11.

Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo Activity.

J Med Chem. 2021 Aug 26;64(16):12261-12272. doi: 10.1021/acs.jmedchem.1c00896. Epub 2021 Aug 12.

Environmental Subconcussive Injury, Axonal Injury, and Chronic Traumatic Encephalopathy.

Front Neurol. 2018 Mar 27;9:166. doi: 10.3389/fneur.2018.00166. eCollection 2018.

Modulation of Toll-like receptor signaling in innate immunity by natural products.

Int Immunopharmacol. 2016 Aug;37:65-70. doi: 10.1016/j.intimp.2016.02.005. Epub 2016 Feb 15.

Characterization of TRIF selectivity in the AGP class of lipid A mimetics: role of secondary lipid chains.

Bioorg Med Chem Lett. 2015 Feb 1;25(3):547-53. doi: 10.1016/j.bmcl.2014.12.024. Epub 2014 Dec 17.

A comparative review of toll-like receptor 4 expression and functionality in different animal species.

Front Immunol. 2014 Jul 10;5:316. doi: 10.3389/fimmu.2014.00316. eCollection 2014.